Knight v. Xellia Pharmaceuticals USA, LLC
Plaintiff: Kurt Knight
Defendant: Xellia Pharmaceuticals USA, LLC
Case Number: 1:2024cv02489
Filed: September 10, 2024
Court: US District Court for the District of Colorado
Presiding Judge: N Reid Neureiter
Nature of Suit: Civil Rights: Americans with Disabilities - Employment
Cause of Action: 42 U.S.C. ยง 12111 - Americans With Disabilities Act - Employment
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on November 7, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 7, 2024 Filing 10 CORPORATE DISCLOSURE STATEMENT. (Masoudpour, Mikaela)
November 6, 2024 Opinion or Order Filing 9 MINUTE ORDER The Joint Stipulation for Extension of Time for Defendant to Answer or Otherwise Respond to Plaintiff's Complaint (ECF No. #8 ), which was docketed as a motion, is GRANTED. Defendant shall answer or otherwise respond to Plaintiff's Complaint (ECF No. #1 ) on or before December 3, 2024. PLEASE READ ATTACHED MINUTE ORDER. Entered by Magistrate Judge N. Reid Neureiter on 11/6/2024.(norlin, )
November 6, 2024 Filing 8 Stipulated MOTION for Extension of Time to File Answer or Otherwise Respond - Joint by Defendant Xellia Pharmaceuticals USA, LLC. (Masoudpour, Mikaela)
October 7, 2024 Filing 7 NOTICE of Entry of Appearance by Mikaela Shaw Masoudpour on behalf of Xellia Pharmaceuticals USA, LLCAttorney Mikaela Shaw Masoudpour added to party Xellia Pharmaceuticals USA, LLC(pty:dft) (Masoudpour, Mikaela)
September 17, 2024 Filing 6 WAIVER OF SERVICE Returned Executed by Kurt Knight. Xellia Pharmaceuticals USA, LLC waiver sent on 9/13/2024, answer due 11/12/2024. (Guesno, Jacqueline)
September 11, 2024 Filing 5 NOTICE of Entry of Appearance of Jacqueline Guesno by Jacqueline Raquel Guesno on behalf of Kurt KnightAttorney Jacqueline Raquel Guesno added to party Kurt Knight(pty:pla) (Guesno, Jacqueline)
September 10, 2024 Opinion or Order Filing 4 ORDER SETTING SCHEDULING/PLANNING CONFERENCE AND SETTINGDEADLINE FOR FILING OF CONSENT/NON-CONSENT FORM IT IS HEREBY ORDERED that Plaintiff shall promptly serve Defendant. On or before December 3, 2024, the parties shall complete and file the Consent/Non-Consent Form (see Dkt. #3 -1), indicating either unanimous consent of the parties or that consent has been declined. Please note that this date may be earlier than the default deadlines contemplated by D.C.COLO.LCivR 40.1(c)(4). A Scheduling/Planning Conference pursuant to Fed.R.Civ.P.16(b) shall be held on: December 17, 2024 at 10:30 a.m. in Courtroom A-401, Fourth Floor, Alfred A. Arraj United States Courthouse, 901 19th Street, Denver, Colorado 80294 The Scheduling Conference will be conducted via telephone. Five minutes prior to the start of the hearing, the parties are directed to call the conference line as a participant at (571) 353-2301, Access Code 841686937#. If this date is not convenient for any counsel/pro se party, he/she should confer with opposing counsel/pro se party and file a motion to reschedule the conference to a more convenient date. Absent exceptional circumstances, no request for rescheduling any appearance in this court will be entertained unless a motion is filed no less than FIVE (5) business days in advance of the date of appearance. PLEASE READ ATTACHED ORDER. Entered by Magistrate Judge N. Reid Neureiter on 9/10/2024. (norlin, )
September 10, 2024 Filing 3 SUMMONS issued by Clerk. (Attachments: #1 Magistrate Judge Consent Form) (agryan)
September 10, 2024 Filing 2 Case assigned to Magistrate Judge N. Reid Neureiter. Text Only Entry. (agryan)
September 10, 2024 Filing 1 COMPLAINT AND JURY DEMAND against Xellia Pharmaceuticals USA, LLC (Filing fee $ 405,Receipt Number ACODC-9864837)Attorney Andrew C. Quisenberry added to party Kurt Knight(pty:pla), filed by Kurt Knight. (Attachments: #1 Civil Cover Sheet, #2 Summons)(Quisenberry, Andrew)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Colorado District Court's Electronic Court Filings (ECF) System

Search for this case: Knight v. Xellia Pharmaceuticals USA, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Kurt Knight
Represented By: Andrew C. Quisenberry
Represented By: Jacqueline Raquel Guesno
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Xellia Pharmaceuticals USA, LLC
Represented By: Mikaela Shaw Masoudpour
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?